BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 31997062)

  • 1. Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.
    Wu YT; Luo HL; Wang HJ; Chen YT; Cheng YT; Chiang PH
    Int Urol Nephrol; 2020 Jun; 52(6):1043-1048. PubMed ID: 31997062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort.
    Luo HL; Ohyama C; Hatakeyama S; Wang HJ; Yoneyama T; Yang WC; Chuang YC; Chen YT; Lee WC; Cheng YT; Kang CH; Chiang PH
    Int J Urol; 2020 Apr; 27(4):327-332. PubMed ID: 32100370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study.
    Kim BW; Ha YS; Lee JN; Kim HT; Kim TH; Lee JK; Byun SS; Choi YD; Kang HW; Yun SJ; Kim WJ; Kwon YS; Kwon TG
    Urol J; 2015 Sep; 12(4):2233-9. PubMed ID: 26341764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
    Yu TY; Wang HJ; Sung MT; Chuang YC; Chen YT; Cheng YT; Kang CH; Liu HY; Chang YL; Luo HL
    Int J Urol; 2024 Apr; 31(4):410-418. PubMed ID: 38169055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.
    Lee HY; Yeh HC; Wu WJ; He JS; Huang CN; Ke HL; Li WM; Li CF; Li CC
    World J Surg Oncol; 2018 Jul; 16(1):135. PubMed ID: 29986730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
    Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
    Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
    Kuroiwa K; Inokuchi J; Nishiyama H; Kojima T; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yokomizo A; Matsuyama H; Ichikawa T; Mizusawa J; Eba J; Naito S;
    J Urol; 2019 Dec; 202(6):1127-1135. PubMed ID: 31251717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.
    Kim SH; Song MK; Joung JY; Chung J; Lee KH; Seo HK
    Investig Clin Urol; 2019 Nov; 60(6):432-442. PubMed ID: 31692890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Naser-Tavakolian A; Ghodoussipour S; Djaladat H
    Curr Opin Urol; 2019 May; 29(3):189-197. PubMed ID: 30762673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Liu J; Wu P; Lai S; Song X; Fu C; Wang X; Liu S; Hou H; Liu M; Wang J
    Clin Genitourin Cancer; 2021 Jun; 19(3):e156-e165. PubMed ID: 33121908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is bladder preservation safe? The oncology outcomes of patients after 2-sided radical nephroureterectomies due to bilateral upper urinary tract urothelial carcinomas.
    Kao YL; Yang WH; Ou CH
    Int Urol Nephrol; 2022 Jan; 54(1):63-69. PubMed ID: 34783981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.
    Rink M; Xylinas E; Trinh QD; Lotan Y; Margulis V; Raman JD; Fisch M; Lee RK; Chun FK; Abdennabi J; Seitz C; Pycha A; Zlotta AR; Karakiewicz PI; Babjuk M; Scherr DS; Shariat SF;
    BJU Int; 2013 Sep; 112(5):623-37. PubMed ID: 23465088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.
    Liu JY; Dai YB; Zhou FJ; Long Z; Li YH; Xie D; Liu B; Tang J; Tan J; Yao K; He LY
    BMC Surg; 2017 Jan; 17(1):8. PubMed ID: 28095848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of post-void residual urine volume on intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sazuka T; Sakamoto S; Nakamura K; Imamura Y; Yamamoto S; Komiya A; Ichikawa T
    Int J Urol; 2019 Dec; 26(12):1106-1112. PubMed ID: 31522458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma.
    Hou G; Zheng Y; Zhang L; Lai D; Wang F; Li X; Yan F; Tian J; Zhang G; Meng P; Wei D; Zhu Z; Yuan J; Hui Q; Yuan J
    World J Urol; 2020 Aug; 38(8):1969-1975. PubMed ID: 31654221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.